Long-term exposure to air pollution leaves molecular traces in human blood that can signal the development of lung cancer years before diagnosis, according to research published in Nature Communications.
Researchers examined blood samples from 1,357 individuals who were free of cancer at the time of the study. The team evaluated the participants' level of exposure to polluted air and compared it against changes in their blood levels of metabolites, which are small molecules that reflect cellular metabolic activity.
The analysis revealed that individuals exposed to higher concentrations of air pollution exhibited distinct biological disruptions years prior to receiving a cancer diagnosis. These metabolic shifts occurred specifically within processes governing chronic inflammation, oxidative stress, cellular detoxification, and energy metabolism. Study authors noted that all four of these cellular disruptions were previously established as biological markers associated with an elevated risk of developing lung cancer.
Metabolites act as key biological indicators in medical research, providing real-time insights into how environmental toxins, diet, and lifestyle influence human physiology. Nature Communications is a peer-reviewed scientific journal that publishes research across the natural sciences. Environmental health researchers increasingly analyze metabolic profiles to detect early cellular damage caused by ambient particulate matter before structural organ damage occurs.
Screening gap for non-smokers
Study authors emphasized that the findings carry significant implications for individuals who have never smoked. Although tobacco use remains the leading primary risk factor for lung malignancies, a substantial proportion of lung cancer cases occur in non-smokers. Current medical screening guidelines rely heavily on smoking history to identify candidates for preventative scans, meaning many non-smoking individuals with elevated risk currently remain outside the scope of clinical observation.
Standard early detection protocols for lung cancer primarily utilize low-dose computed tomography scans, which are routinely recommended only for long-term heavy smokers. Because non-smokers rarely qualify for routine preventative imaging under existing public health criteria, their malignancies are frequently diagnosed at more advanced stages when treatment options become more limited.
The study authors stressed that the identified molecular changes cannot yet be used as a direct clinical diagnostic tool for patients. However, they pointed out that these biological signatures could eventually form the groundwork for a specialized blood test capable of identifying high-risk individuals long before physical symptoms emerge.
Lifestyle factors and cancer risk
The discovery adds to growing scientific interest in preventative oncology and early detection biomarkers. The study follows earlier research showing that adding just 15 minutes of physical activity to a daily routine reduces overall cancer risk by 2 percent.
Regular physical exercise is widely recognized by medical health organizations for its ability to lower systemic inflammation, improve metabolic regulation, and enhance immune surveillance against abnormal cell growth. As research into environmental factors and daily habits expands, healthcare experts hope that combining biomarker screening with lifestyle interventions will help reduce overall cancer incidence.
